Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration

被引:36
作者
Nowak, M
Swietochowska, E
Wielkoszynski, T
Marek, B
Karpe, J
Górski, J
Glogowska-Szelag, J
Kos-Kudla, B
Ostrowska, Z
机构
[1] Silesian Univ Med, Dept Pathophysiol & Endocrinol, Div Pathophysiol, PL-41800 Zabrze, Poland
[2] Silesian Univ Med, Dept Clin Biochem, PL-41800 Zabrze, Poland
[3] Silesian Univ Med, Dept Chem, PL-41800 Zabrze, Poland
[4] Silesian Univ Med, Dept Anesthesiol, PL-41800 Zabrze, Poland
关键词
AMD; antioxidants; vitamins; lipid peroxidation;
D O I
10.1177/112067210301300307
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The aim of this study was to evaluate the ferric reducing ability of plasma (FRAP), selected enzymatic and non-enzymatic components of the antioxidative system, and the intensity of peroxidative processes in the blood of patients with age-related macular degeneration (AMD). METHODS. In the peripheral blood, we evaluated FRAP; concentrations of vitamins C, A, and E, and of thiols. We assayed the activity of enzymatic components of the antioxidative system-superoxide dismutase, catalase, ceruloplasmin and the concentration of reduced glutathione as an indicator of glutathione peroxidase activity. In order to determine the intensity of lipid peroxidation, we measured the concentrations of malondialdehyde and hydroxyalkenales (MDA-HNA) and conjugated diens (CD). RESULTS. We found a significant increase in FRAP in patients with AMD compared with the control group. The average concentrations of vitamins A and C were low and vitamins E and GSH were significantly higher in AMD than in the control group. The activity of almost all the antioxidative enzymes was high. We found a significant increase in MDA-HNA but no difference in CD. CONCLUSIONS. The significantly higher concentration of lipid peroxidation products in patients with AMD indicates an important pathogenic role of oxido-reduction disturbance. The high FRAP concentration may be one of the protective mechanisms in oxidation stress. The adaptive increase of the antioxidant barrier mostly involves the enzymatic components.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 31 条
[1]  
ABBEY M, 1995, NUTR REV, V53, pS28
[2]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[3]  
[Anonymous], 1993, Arch Ophthalmol, V111, P104
[4]  
Beatty S, 2001, INVEST OPHTH VIS SCI, V42, P439
[5]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[6]   AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION [J].
BIRD, AEC ;
BRESSLER, NM ;
BRESSLER, SB ;
CHISHOLM, IH ;
COSCAS, G ;
DAVIS, MD ;
DEJONG, PTVM ;
KLAVER, CCW ;
KLEIN, BEK ;
KLEIN, R ;
MITCHELL, P ;
SARKS, JP ;
SARKS, SH ;
SOURBANE, G ;
TAYLOR, HR ;
VINGERLING, JR .
SURVEY OF OPHTHALMOLOGY, 1995, 39 (05) :367-374
[7]  
Bland Jeffrey S., 1995, Journal of Nutritional and Environmental Medicine (Abingdon), V5, P255, DOI 10.3109/13590849509000226
[8]  
BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P552
[9]  
Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235
[10]  
Browne R W, 1998, Methods Mol Biol, V108, P347